A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.

Clinical trial NCT06663943 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06663943
Sponsor: Chao Ji
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pemphigus Disease Pemphigus Vulgaris (PV)

Start date: 2025-10-01
Primary completion: 2026-10-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.